Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Havva Pehlivanoglu

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The Journal of Antimicrobial Chemotherapy|October 24, 2019
Repurposing auranofin as a Clostridioides difficile therapeuticMelanie L Hutton, Havva Pehlivanoglu, Callum J Vidor, et al.
Life Science Alliance|February 17, 2026
Acetyl-carnitine improves hyperactivity and learning deficits in <i>KAT6A</i> haploinsufficient miceSamantha Eccles, Hannah K Vanyai, Maria I Bergamasco, et al.
Cell Chemical Biology|August 9, 2023
Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancerShikhar Sharma, Chi-Yeh Chung, Sean Uryu, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The Journal of Antimicrobial Chemotherapy|October 24, 2019
Repurposing auranofin as a Clostridioides difficile therapeuticMelanie L Hutton, Havva Pehlivanoglu, Callum J Vidor, et al.
Life Science Alliance|February 17, 2026
Acetyl-carnitine improves hyperactivity and learning deficits in <i>KAT6A</i> haploinsufficient miceSamantha Eccles, Hannah K Vanyai, Maria I Bergamasco, et al.
Cell Chemical Biology|August 9, 2023
Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancerShikhar Sharma, Chi-Yeh Chung, Sean Uryu, et al.
Pageof 1